Open AccessP354: REAL‐WORLD ANALYSIS OF THE RISKS OF THROMBOTIC AND BLEEDING EVENTS IN PATIENTS RECEIVING PEGYLATED ASPARAGINASE FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
Author(s) -
Mautner B.,
Brewer B.,
Mort J.,
Pierce E.,
Ghamsari F.,
Dibenedetto S.,
Morse E.,
Wells L.,
Morris A.,
Allen C.,
Patel I.,
D'Souza D.,
Jackson C.,
Perciavalle M.,
Yelvington B.,
Miller R.,
Abernathy K.,
Walsh K.,
Wolfe H.,
Locke S.,
Reed D.,
Duong V.,
Dholaria B.,
LeBlanc T.,
Shallis R.,
Keng M.,
Horton B.,
El Chaer F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844304.82725.a0
Subject(s) - medicine , antithrombotic , coagulopathy , fibrinogen , thrombosis , chemotherapy , asparaginase , exact test , induction chemotherapy , antithrombin , lymphoblastic leukemia , gastroenterology , surgery , heparin , leukemia